| Literature DB >> 23652240 |
James C L Chow1, Runqing Jiang.
Abstract
This study investigates the dosimetry and radiobiological model variation when a second photon arc was added to prostate volumetric-modulated arc therapy (VMAT) using the single-arc technique. Dosimetry and radiobiological model comparison between the single-arc and double-arc prostate VMAT plans were performed on five patients with prostate volumes ranging from 29-68.1 cm3. The prescription dose was 78 Gy/39 fractions and the photon beam energy was 6 MV. Dose-volume histogram, mean and maximum dose of targets (planning and clinical target volume) and normal tissues (rectum, bladder and femoral heads), dose-volume criteria in the treatment plan (D99% of PTV; D30%, D50%, V17Gy and V35Gy of rectum and bladder; D5% of femoral heads), and dose profiles along the vertical and horizontal axis crossing the isocenter were determined using the single-arc and double-arc VMAT technique. For comparison, the monitor unit based on the RapidArc delivery method, prostate tumor control probability (TCP), and rectal normal tissue complication probability (NTCP) based on the Lyman-Burman-Kutcher algorithm were calculated. It was found that though the double-arc technique required almost double the treatment time than the single-arc, the double-arc plan provided a better rectal and bladder dose-volume criteria by shifting the delivered dose in the patient from the anterior-posterior direction to the lateral. As the femoral head was less radiosensitive than the rectum and bladder, the double-arc technique resulted in a prostate VMAT plan with better prostate coverage and rectal dose-volume criteria compared to the single-arc. The prostate TCP of the double-arc plan was found slightly increased (0.16%) compared to the single-arc. Therefore, when the rectal dose-volume criteria are very difficult to achieve in a single-arc prostate VMAT plan, it is worthwhile to consider the double-arc technique.Entities:
Mesh:
Year: 2013 PMID: 23652240 PMCID: PMC5714414 DOI: 10.1120/jacmp.v14i3.4053
Source DB: PubMed Journal: J Appl Clin Med Phys ISSN: 1526-9914 Impact factor: 2.102
Prostate volumes, PTVs, critical organ volumes (rectum, bladder and femoral head), and monitor units of the single‐arc and double‐arc prostate VMAT plans for the five patients.
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|
|
|
| |||||||
| 1 | 29.0 | 107.0 | 42.3 | 182.5 | 146.6 | 153.4 | 550 | 598 |
| 2 | 39.7 | 134.1 | 110.1 | 379.5 | 190.4 | 189.0 | 519 | 676 |
| 3 | 54.8 | 170.4 | 80.1 | 552.6 | 201.4 | 246.0 | 471 | 587 |
| 4 | 57.3 | 176.7 | 50.2 | 243.9 | 199.7 | 193.7 | 600 | 610 |
| 5 | 68.1 | 196.1 | 76.8 | 184.5 | 180.0 | 198.2 | 540 | 730 |
Figure 1Average dose‐volume histograms of the (a) PTV, (b) rectum, (c) bladder, (d) left femoral head, and (e) right femoral head for the single‐arc and double‐arc prostate VMAT plans.
Mean dose‐volume criteria, and average mean and maximum doses of the PTV, CTV, and critical organs for the single‐arc and double‐arc prostate VMAT plans. The standard deviations are shown inside the brackets. and are percentage volumes receiving at least 17 Gy and 35 Gy, respectively. , and are doses given to 5%, 30%, 50%, and 99% of volumes, respectively.
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|
| Single‐arc |
| 72.5 (0.8) | – | – | – | – | – |
|
| – | – | 34.7 (6.1) | 28.3 (8.4) | – | – | |
|
| – | – | 22.3 (4.6) | 10.6 (6.4) | – | – | |
|
| – | – | – | – | 31.0 (6.6) | 28.4 (4.9) | |
|
| – | – | 29.6 (5.9) | 25.1 (5.3) | – | – | |
|
| – | – | 61.1 (8.5) | 40.7 (9.8) | – | – | |
| Mean dose (Gy) | 78.3 (0.7) | 80.1 (0.7) | 28.0 (3.9) | 22.2 (4.3) | 16.6 (4.0) | 15.8 (1.8) | |
| Maximum dose (Gy) | 82.7 (0.8) | 82.6 (0.7) | 80.1 (0.8) | 80.7 (1.4) | 40.4 (5.7) | 38.9 (3.8) | |
| Double‐arc |
| 74.6 (0.4) | – | – | – | – | – |
|
| – | – | 28.5 (6.6) | 22.2 (7.0) | – | – | |
|
| – | – | 15.9 (3.1) | 9.2 (3.7) | – | – | |
|
| – | – | – | – | 41.6 (2.1) | 39.4 (3.9) | |
|
| – | – | 25.1 (4.9) | 20.8 (4.9) | – | – | |
|
| – | – | 47.7 (9.0) | 35.4 (7.8) | – | – | |
| Mean dose (Gy) | 78.7 (0.8) | 80.3 (0.6) | 25.1 (3.6) | 20.4 (3.9) | 24.9 (2.5) | 21.1 (3.8) | |
| Maximum dose (Gy) | 82.8 (0.7) | 82.9 (0.8) | 80.1 (0.8) | 80.7 (1.1) | 49.4 (2.4) | 47.1 (5.8) |
Figure 2Dose profiles of the (a) left, (b) right, (c) anterior, and (d) posterior directions for the single‐arc and double‐arc prostate VMAT plans of five patients. The origin represents the isocenter. The negative values in the x‐axes represent the left and anterior direction.
Figure 3Prostate TCP (a) and rectal NTCP (b) varying with the prostate volume of the five patients based on the single‐arc and double‐arc prostate VMAT plans.